-
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
NCT07266831 ·
Phase: Phase 2, Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Texas: Bellaire, Dallas, Fort Worth, Longview
-
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
NCT07044297 ·
Phase: Phase 3 ·
Ages: 16 Years and older ·
Sex: All (male and female)
· Texas: Austin, Bellaire
-
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
NCT05719441 ·
Phase: Phase 2 ·
Ages: 18 Years to 70 Years ·
Sex: All (male and female)
· Texas: Dallas, Houston
-
A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV
NCT07698600 ·
Phase: Phase 1 ·
Ages: 18 Years to 50 Years ·
Sex: All (male and female)
· Texas: Houston
-
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
NCT07202546 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Texas: Bellaire, Dallas, Houston, Longview
-
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
NCT04139304 ·
Phase: Early Phase 1 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Texas: Houston
-
A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1
NCT07390955 ·
Phase: Phase 1 ·
Ages: 18 Years to 55 Years ·
Sex: All (male and female)
· Texas: Houston
-
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV
NCT06724640 ·
Phase: Phase 1 ·
Ages: 18 Years to 55 Years ·
Sex: All (male and female)
· Texas: Austin
-
A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
NCT07143968 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Texas: Houston
-
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
NCT07650916 ·
Phase: Phase 3 ·
Ages: 12 Years and older ·
Sex: All (male and female)
· Texas: Austin, Dallas, El Paso, Houston
-
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
NCT05418868 ·
Phase: Phase 1 ·
Ages: 18 Years to 55 Years ·
Sex: All (male and female)
· Texas: Austin
-
A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan Antibodies
NCT07569029 ·
Phase: Phase 1 ·
Ages: 18 Years to 60 Years ·
Sex: All (male and female)
· Texas: Houston
-
ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV
NCT06274632 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Texas: Houston
-
Assessing the Use of MY-RIDE, a Just-in-time Adaptive Intervention, to Improve HIV Prevention and Substance Use in Youth Experiencing Homelessness
NCT06074354 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 25 Years ·
Sex: All (male and female)
· Texas: Houston
-
Behavioral Economic Intervention to Improve HIV Behaviors in Sexual Minority Individuals
NCT06745947 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 34 Years ·
Sex: All (male and female)
· Texas: San Antonio
-
CHOICES-TEEN Randomized Controlled Trial
NCT05368571 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 14 Years to 19 Years ·
Sex: Female
· Texas: Houston
-
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
NCT05488431 ·
Phase: Phase 2 ·
Ages: 40 Years and older ·
Sex: All (male and female)
· Texas: Houston
-
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
NCT02479698 ·
Phase: Phase 2 ·
Ages: No age limits stated ·
Sex: All (male and female)
· Texas: Houston
-
Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1
NCT06071767 ·
Phase: Phase 1, Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Texas: Houston
-
Evaluation of a Novel Optical Microscope With a Deep Depth of Field (DeepDOF) to Provide Histologic-quality Images on Cervical Biopsies and Loop Electrosurgical Excision Procedure (LEEP) Specimens at the Point-of-care
NCT06850402 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 25 Years to 49 Years ·
Sex: Female
· Texas: Houston
-
First Time in Human Study of Long Acting VH4524184 Formulations
NCT06310551 ·
Phase: Phase 1 ·
Ages: 18 Years to 55 Years ·
Sex: All (male and female)
· Texas: San Antonio
-
HIV Pre-Exposure Prophylaxis (PrEP) Linkage With Immediate Medications in the Emergency Department Study
NCT07462611 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Texas: Dallas
-
HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients
NCT06659952 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Texas: Dallas
-
HOTSPOT Study: Implement and Evaluate the PrEP (Pre-exposure Prophylaxis) Implementation Strategy
NCT06919419 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Texas: Dallas
-
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
NCT04949464 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 45 Years to 80 Years ·
Sex: All (male and female)
· Texas: Houston
-
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
NCT07473778 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Texas: Dallas, Houston
-
Incretin Microdosing for Cardiometabolic Health in People With HIV
NCT07325500 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Texas: Houston
-
Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
NCT06263426 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Texas: Houston
-
Menopausal HT for Women Living With HIV (HoT)
NCT06856174 ·
Phase: Phase 4 ·
Ages: 40 Years to 60 Years ·
Sex: Female
· Texas: Houston
-
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
NCT05674656 ·
Phase: Phase 1, Phase 2 ·
Ages: 6 Years to 12 Years ·
Sex: All (male and female)
· Texas: Houston
-
Positive Peers Intervention Clinical Trial
NCT06388109 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 13 Years to 34 Years ·
Sex: All (male and female)
· Texas: Houston
-
Pre-exposure Prophylaxis (PrEP) Adherence Intervention for Women with Substance Use Disorders
NCT06158607 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 60 Years ·
Sex: Female
· Texas: Houston
-
Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions
NCT06558825 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: Female
· Texas: Houston
-
RESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entry
NCT07136363 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Texas: Dallas
-
Screen2Prevent (S2P)
NCT07728123 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 14 Years to 24 Years ·
Sex: All (male and female)
· Texas: Houston
-
Shared Decision Making to Treat Or Prevent (STOP) HIV in Criminal Legal Involved Populations (R33)
NCT07223398 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Texas: Dallas, Fort Worth
-
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
NCT07682961 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Texas: Dallas
-
Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV
NCT07040319 ·
Phase: Phase 1, Phase 2 ·
Ages: 16 Years to 45 Years ·
Sex: Female
· Texas: Houston
-
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
NCT06343311 ·
Phase: Phase 1, Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Texas: Dallas
-
The Unlocking PrEP Study: Integration of Peer Health Navigation Into Comprehensive Re-entry Services
NCT07292792 ·
Phase: Not specified ·
Ages: 18 Years to 99 Years ·
Sex: All (male and female)
· Texas: Dallas
-
This Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasma. Samples From At-risk, HIV-positive, Pregnant, and Healthy Individuals Will Assess Assay Performance Versus Established Comparator Tests.
NCT07089836 ·
Phase: Not specified ·
Ages: 13 Years and older ·
Sex: All (male and female)
· Texas: Houston, Mesquite
-
Trial of Ixazomib for Kaposi Sarcoma
NCT04305691 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Texas: Houston
-
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
NCT02140255 ·
Phase: Phase 1, Phase 2 ·
Ages: Up to 48 Hours ·
Sex: All (male and female)
· Texas: Houston